DaVita Inc. $DVA Shares Sold by Quantinno Capital Management LP

Quantinno Capital Management LP cut its position in DaVita Inc. (NYSE:DVA) by 13.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 232,666 shares of the company’s stock after selling 35,610 shares during the quarter. Quantinno Capital Management LP’s holdings in DaVita were worth $35,759,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Root Financial Partners LLC grew its stake in shares of DaVita by 128.0% during the first quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock valued at $29,000 after acquiring an additional 105 shares in the last quarter. Caitlin John LLC acquired a new stake in DaVita during the 4th quarter valued at approximately $34,000. Canada Pension Plan Investment Board purchased a new stake in DaVita during the 2nd quarter worth approximately $43,000. Sankala Group LLC purchased a new stake in DaVita during the 4th quarter worth approximately $39,000. Finally, iSAM Funds UK Ltd acquired a new position in shares of DaVita in the 3rd quarter valued at approximately $46,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

Insider Buying and Selling

In other news, insider Kathleen Alyce Waters sold 15,405 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the completion of the transaction, the insider directly owned 109,194 shares of the company’s stock, valued at approximately $22,756,029.60. This represents a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Joel Ackerman sold 51,471 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $192.10, for a total value of $9,887,579.10. Following the sale, the chief financial officer owned 132,434 shares in the company, valued at $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DVA. Weiss Ratings reissued a “hold (c+)” rating on shares of DaVita in a research report on Monday, June 8th. Deutsche Bank Aktiengesellschaft raised shares of DaVita from a “hold” rating to a “buy” rating and upped their price target for the company from $126.00 to $220.00 in a report on Wednesday, May 6th. UBS Group raised their price objective on shares of DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a report on Friday, July 10th. Truist Financial boosted their target price on shares of DaVita from $205.00 to $250.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Finally, TD Cowen upped their target price on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research note on Monday, May 11th. Two analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $216.50.

DaVita Price Performance

DVA stock opened at $239.19 on Friday. The firm has a market cap of $15.36 billion, a price-to-earnings ratio of 22.19, a PEG ratio of 0.79 and a beta of 0.88. DaVita Inc. has a 1-year low of $101.00 and a 1-year high of $244.49. The firm has a fifty day moving average price of $216.92 and a two-hundred day moving average price of $172.66.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The company had revenue of $3.42 billion for the quarter, compared to the consensus estimate of $3.36 billion. During the same period last year, the firm posted $2.00 EPS. The company’s revenue for the quarter was up 6.0% on a year-over-year basis. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, analysts expect that DaVita Inc. will post 15.07 EPS for the current fiscal year.

DaVita Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.